Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

LRMR holding history

Larimar Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LRMR overviewAll 13F holders of LRMRFull Q2 2026 holdings

Shares (Q2 2026)
961,083
Value
$2.93M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of LRMR by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026961,083$2.93M<0.1%+162,621+20.4%AddedHolders
Q1 2026798,462$3.59M<0.1%+470,968+143.8%AddedHolders
Q4 2025327,494$1.25M<0.1%+271,237+482.1%AddedHolders
Q3 202556,257$181.7K<0.1%+24,903+79.4%AddedHolders
Q2 202531,354$90.6K<0.1%−41,295−56.8%ReducedHolders
Q1 202572,649$156.2K<0.1%−8,501−10.5%ReducedHolders
Q4 202481,150$314.1K<0.1%−25,753−24.1%ReducedHolders
Q3 2024106,903$700.2K<0.1%−38,820−26.6%ReducedHolders
Q2 2024145,723$1.06M<0.1%−30,021−17.1%ReducedHolders
Q1 2024175,744$1.33M<0.1%−19,444−10.0%ReducedHolders
Q4 2023195,188$888.4K<0.1%−29,038−13.0%ReducedHolders
Q3 2023224,226$888.0K<0.1%−94,683−29.7%ReducedHolders
Q2 2023318,909$998.2K<0.1%+153,467+92.8%AddedHolders
Q1 2023165,442$749.5K<0.1%+101,275+157.8%AddedHolders
Q4 202264,167$265.0K<0.1%+34,955+119.7%AddedHolders
Q3 202229,212$93.0K<0.1%+4,474+18.1%AddedHolders
Q2 202224,738$48.0K<0.1%−3,400−12.1%ReducedHolders
Q1 202228,138$114.0K<0.1%00.0%UnchangedHolders
Q4 202128,138$304.0K<0.1%+12,731+82.6%AddedHolders
Q3 202115,407$178.0K<0.1%+15,407NewHolders
Q2 20210$00.0%−13,842−100.0%Sold outHolders
Q1 202113,842$202.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.